{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:12:59Z","timestamp":1784970779700,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":188,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011898","name":"Marianne och Marcus Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005701","name":"\u00c5hl\u00e9n-stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["-03075"],"award-info":[{"award-number":["-03075"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021594","name":"Stiftelsen Demensfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010773","name":"Demensf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004032","name":"Parkinson Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska Lakaresallskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Aging Brain"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nbas.2023.100086","type":"journal-article","created":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T16:54:59Z","timestamp":1690736099000},"page":"100086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against \u03b1-synuclein oligomers\/protofibrils"],"prefix":"10.1016","volume":"4","author":[{"given":"S.","family":"Ekmark-Lew\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aniszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Molisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gumucio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Kahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"F\u00e4lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lannfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-8370","authenticated-orcid":false,"given":"M.","family":"Ingelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5999","key":"10.1016\/j.nbas.2023.100086_b0005","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.nbas.2023.100086_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2011.01.064","article-title":"Decreased reuptake of dopamine in the dorsal striatum in the absence of alpha-synuclein","volume":"1382","author":"Chadchankar","year":"2011","journal-title":"Brain Res"},{"issue":"6645","key":"10.1016\/j.nbas.2023.100086_b0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.nbas.2023.100086_b0020","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in alpha-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"34","key":"10.1016\/j.nbas.2023.100086_b0030","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.nbas.2023.100086_b0035","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.nbas.2023.100086_b0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/039463200902200405","article-title":"Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils","volume":"22","author":"Wilms","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"10.1016\/j.nbas.2023.100086_b0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.nbas.2023.100086_b0060","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain","volume":"20","author":"Kahle","year":"2000","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.nbas.2023.100086_b0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies","volume":"110","author":"Neumann","year":"2002","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.nbas.2023.100086_b0070","doi-asserted-by":"crossref","first-page":"e00915","DOI":"10.1002\/brb3.915","article-title":"Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"4;8","author":"Ekmark-Lew\u00e9n","year":"2018","journal-title":"Brain Behav"},{"issue":"9","key":"10.1016\/j.nbas.2023.100086_b0075","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.neurobiolaging.2006.06.013","article-title":"Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice","volume":"28","author":"Freichel","year":"2007","journal-title":"Neurobiol Aging"},{"issue":"39","key":"10.1016\/j.nbas.2023.100086_b0080","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1523\/JNEUROSCI.1292-12.2012","article-title":"Antibody-Aided Clearance of Extracellular alpha-Synuclein Prevents Cell-to-Cell Aggregate Transmission","volume":"32","author":"Bae","year":"2012","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.nbas.2023.100086_b0085","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-014-1256-4","article-title":"Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials","volume":"127","author":"Mandler","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.nbas.2023.100086_b0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","article-title":"Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease","volume":"46","author":"Masliah","year":"2005","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.nbas.2023.100086_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019338","article-title":"Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease","volume":"6","author":"Masliah","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2217\/imt.13.162","article-title":"Immunotherapy targeting alpha-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders","volume":"6","author":"Lindstrom","year":"2014","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13311-015-0397-z","article-title":"Immunotherapeutic Approaches Targeting Amyloid-beta, alpha-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders","volume":"13","author":"Valera","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.12175","article-title":"Monoclonal antibodies selective for alpha-synuclein oligomers\/protofibrils recognize brain pathology in Lewy body disorders and alpha-synuclein transgenic mice with the disease-causing A30P mutation","volume":"126","author":"Fagerqvist","year":"2013","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10571-016-0352-5","article-title":"Cellular Uptake of alpha-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of alpha-Synuclein and Mediated via Fcgamma Receptors","volume":"37","author":"Gustafsson","year":"2017","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"10.1016\/j.nbas.2023.100086_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027230","article-title":"Antibodies against alpha-synuclein reduce oligomerization in living cells","volume":"6","author":"Nasstrom","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbas.2023.100086_b0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2014.05.009","article-title":"Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"69","author":"Lindstrom","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"Ito","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"issue":"5","key":"10.1016\/j.nbas.2023.100086_b0135","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","article-title":"Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain","volume":"32","author":"Ito","year":"2001","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.nbas.2023.100086_b0140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of Cinpanemab in Early Parkinson's Disease","volume":"387","author":"Lang","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.nbas.2023.100086_b0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of Prasinezumab in Early-Stage Parkinson's Disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N Engl J Med"},{"issue":"9533","key":"10.1016\/j.nbas.2023.100086_b0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.nbas.2023.100086_b0155","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.neurobiolaging.2007.11.022","article-title":"A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice","volume":"30","author":"Philipson","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.nbas.2023.100086_b0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","article-title":"An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease","volume":"36","author":"Lord","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"40","key":"10.1016\/j.nbas.2023.100086_b0170","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0175","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","article-title":"Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice","volume":"7","author":"Karampetsou","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nbas.2023.100086_b0180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2009.03.002","article-title":"Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice","volume":"160","author":"Schell","year":"2009","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.nbas.2023.100086_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252635","article-title":"Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein","volume":"16","author":"Elfarrash","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-022-01403-x","article-title":"Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies","volume":"10","author":"Koss","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.nbas.2023.100086_b0195","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jnc.14713","article-title":"Antibodies against alpha-synuclein: tools and therapies","volume":"150","author":"Vaikath","year":"2019","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.nbas.2023.100086_b0200","first-page":"441","article-title":"Mild cognitive impairment in Parkinson's disease","volume":"102","author":"Goldman","year":"2011","journal-title":"Minerva Med"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbr.2009.12.036","article-title":"One-trial object recognition in rats and mice: methodological and theoretical issues","volume":"215","author":"Ennaceur","year":"2010","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.nbas.2023.100086_b0210","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroscience.2010.03.032","article-title":"Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels","volume":"167","author":"Goulart","year":"2010","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jneumeth.2007.06.032","article-title":"Automation of the novel object recognition task for use in adolescent rats","volume":"166","author":"Silvers","year":"2007","journal-title":"J Neurosci Methods"},{"issue":"44","key":"10.1016\/j.nbas.2023.100086_b0220","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.1523\/JNEUROSCI.1532-04.2004","article-title":"Entorhinal cortex lesions disrupt the relational organization of memory in monkeys","volume":"24","author":"Buckmaster","year":"2004","journal-title":"J Neurosci"},{"issue":"23","key":"10.1016\/j.nbas.2023.100086_b0225","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.20-23-08853.2000","article-title":"Impaired recognition memory in rats after damage to the hippocampus","volume":"20","author":"Clark","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.nbas.2023.100086_b0230","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2014.08.002","article-title":"Assessing rodent hippocampal involvement in the novel object recognition task","volume":"285","author":"Cohen","year":"2015","journal-title":"A review Behav Brain Res"},{"issue":"5","key":"10.1016\/j.nbas.2023.100086_b0235","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.neubiorev.2009.08.006","article-title":"NOvelty-related motivation of anticipation and exploration by dopamine (NOMAD): implications for healthy aging","volume":"34","author":"Duzel","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"10.1016\/j.nbas.2023.100086_b0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2011.07.006","article-title":"A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP","volume":"34","author":"Lisman","year":"2011","journal-title":"Trends Neurosci"},{"issue":"49","key":"10.1016\/j.nbas.2023.100086_b0245","doi-asserted-by":"crossref","first-page":"19900","DOI":"10.1073\/pnas.1116727109","article-title":"Role of prefrontal cortex and the midbrain dopamine system in working memory updating","volume":"109","author":"D'Ardenne","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.nbas.2023.100086_b0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2005.05.002","article-title":"The hippocampal-VTA loop: controlling the entry of information into long-term memory","volume":"46","author":"Lisman","year":"2005","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.nbas.2023.100086_b0255","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/jnr.24927","article-title":"Visualization of early oligomeric alpha-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]alpha-syn transgenic mouse model","volume":"99","author":"Behere","year":"2021","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"10.1016\/j.nbas.2023.100086_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-0618(99)00047-2","article-title":"Distribution of dopamine-immunoreactive fibers in the rat brainstem","volume":"18","author":"Kitahama","year":"2000","journal-title":"J Chem Neuroanat"},{"issue":"9","key":"10.1016\/j.nbas.2023.100086_b0265","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/WNR.0b013e3283036e5e","article-title":"Midbrain acetylcholine and glutamate receptors modulate accumbal dopamine release","volume":"19","author":"Lester","year":"2008","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.nbas.2023.100086_b0270","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1460-9568.2003.02511.x","article-title":"Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat","volume":"17","author":"Forster","year":"2003","journal-title":"Eur J Neurosci"},{"issue":"11","key":"10.1016\/j.nbas.2023.100086_b0275","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/01.wnr.0000135692.81613.85","article-title":"Nigrostriatal dopamine release modulated by mesopontine muscarinic receptors","volume":"15","author":"Miller","year":"2004","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0280","doi-asserted-by":"crossref","first-page":"iv","DOI":"10.1176\/jnp.2010.22.1.iv","article-title":"The brainstem: anatomy, assessment, and clinical syndromes","volume":"22","author":"Hurley","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.nbas.2023.100086_b0285","unstructured":"Arguinchona JH, Tadi P. Neuroanatomy, Reticular Activating System. In: StatPearls 2023: Treasure Island (FL)."},{"key":"10.1016\/j.nbas.2023.100086_b0290","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fnagi.2017.00400","article-title":"A Clinical Research Study of Cognitive Dysfunction and Affective Impairment after Isolated Brainstem Stroke","volume":"9","author":"Fu","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"3\u20134","key":"10.1016\/j.nbas.2023.100086_b0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1155\/2003\/872916","article-title":"Cognitive and emotional dysfunction after central pontine myelinolysis","volume":"14","author":"Lee","year":"2003","journal-title":"Behav Neurol"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0305","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/mds.26421","article-title":"Neuropathology of alpha-synuclein propagation and braak hypothesis","volume":"31","author":"McCann","year":"2016","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0310","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2005.10.020","article-title":"The Concentric Square Field: a multivariate test arena for analysis of explorative strategies","volume":"168","author":"Meyerson","year":"2006","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbr.2009.08.020","article-title":"Lower risk taking and exploratory behavior in alcohol-preferring sP rats than in alcohol non-preferring sNP rats in the multivariate concentric square field (MCSF) test","volume":"205","author":"Roman","year":"2009","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.nbas.2023.100086_b0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbr.2007.06.009","article-title":"The multivariate concentric square field test reveals different behavioural profiles in male AA and ANA rats with regard to risk taking and environmental reactivity","volume":"183","author":"Roman","year":"2007","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.nbas.2023.100086_b0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.ps.39.020188.000355","article-title":"Ethoexperimental approaches to the biology of emotion","volume":"39","author":"Blanchard","year":"1988","journal-title":"Annu Rev Psychol"}],"container-title":["Aging Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958923000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958923000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:21:13Z","timestamp":1778905273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589958923000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":65,"alternative-id":["S2589958923000233"],"URL":"https:\/\/doi.org\/10.1016\/j.nbas.2023.100086","relation":{},"ISSN":["2589-9589"],"issn-type":[{"value":"2589-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against \u03b1-synuclein oligomers\/protofibrils","name":"articletitle","label":"Article Title"},{"value":"Aging Brain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbas.2023.100086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100086"}}